Interpretation and validation of interim positron emission tomography in Hodgkin lymphoma.
Carsten
C
Kobe
Markus
M
Dietlein
Michael
M
Fuchs
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D019788:Fluorodeoxyglucose F18 / Q000494:pharmacology; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging* / Q000188:drug therapy; D006801:Humans; D015337:Multicenter Studies as Topic; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods*; D011379:Prognosis; D019275:Radiopharmaceuticals / Q000494:pharmacology; D012015:Reference Standards; D015203:Reproducibility of Results
D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18